Silverfin false false 31/03/2025 01/04/2024 31/03/2025 C Aubrey 30/01/2024 J M Barton 03/10/2024 30/01/2024 K Bourouis 12/01/2023 B S Mainwaring 30/01/2024 M Morton 12/01/2023 E J Norris 30/01/2024 15 December 2025 The company’s principal activity is the development and sale of functional beverages using enhanced absorption technology to improve the uptake of active ingredients.

During the year ended 31 March 2025, the business remained in its investment and pre-commercial testing phase. Turnover of £10,661 reflects limited early launch activity, while the operating loss of £496,716 primarily represents planned expenditure on product development, brand building and establishing a scalable operational base.

A significant proportion of the costs in the period related to the formulation and technical development of the company’s product range. This included multi-layered formulation work, ingredient pairing for efficacy, laboratory batch development, flavour development and controlled testing to validate functional performance. These activities informed the subsequent packaging strategy, ideation, design and execution.

The company also completed a consumer trial with a leading agency (Triyit) and engaged a specialist data science organisation (Beyond Analysis) to produce a comprehensive market report covering the functional food and beverage and vitamins, minerals and supplements sectors, including total addressable market, serviceable addressable market and attainable market analysis. Additional investment was made in brand positioning, development of the SYFA website and a structured UGC, affiliate and influencer test-and-learn cycle to capture early consumer insight.

Collectively, these activities enabled the company to finalise and validate a three-product portfolio, Shift shots, Shift soda and Flare soda, delivered ahead of the Board’s internal timetable. The directors consider that this work has established the product, brand and operational foundations required for the next stage of commercial growth
14588923 2025-03-31 14588923 bus:Director1 2025-03-31 14588923 bus:Director2 2025-03-31 14588923 bus:Director3 2025-03-31 14588923 bus:Director4 2025-03-31 14588923 bus:Director5 2025-03-31 14588923 bus:Director6 2025-03-31 14588923 2024-03-31 14588923 core:CurrentFinancialInstruments 2025-03-31 14588923 core:CurrentFinancialInstruments 2024-03-31 14588923 core:ShareCapital 2025-03-31 14588923 core:ShareCapital 2024-03-31 14588923 core:SharePremium 2025-03-31 14588923 core:SharePremium 2024-03-31 14588923 core:RetainedEarningsAccumulatedLosses 2025-03-31 14588923 core:RetainedEarningsAccumulatedLosses 2024-03-31 14588923 core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill 2024-03-31 14588923 core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill 2025-03-31 14588923 core:OtherPropertyPlantEquipment 2024-03-31 14588923 core:OtherPropertyPlantEquipment 2025-03-31 14588923 bus:OrdinaryShareClass1 2025-03-31 14588923 bus:OrdinaryShareClass2 2025-03-31 14588923 2024-04-01 2025-03-31 14588923 bus:FilletedAccounts 2024-04-01 2025-03-31 14588923 bus:SmallEntities 2024-04-01 2025-03-31 14588923 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 14588923 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 14588923 bus:Director1 2024-04-01 2025-03-31 14588923 bus:Director2 2024-04-01 2025-03-31 14588923 bus:Director3 2024-04-01 2025-03-31 14588923 bus:Director4 2024-04-01 2025-03-31 14588923 bus:Director5 2024-04-01 2025-03-31 14588923 bus:Director6 2024-04-01 2025-03-31 14588923 core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill core:TopRangeValue 2024-04-01 2025-03-31 14588923 core:OtherPropertyPlantEquipment core:TopRangeValue 2024-04-01 2025-03-31 14588923 2023-01-12 2024-03-31 14588923 core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill 2024-04-01 2025-03-31 14588923 core:OtherPropertyPlantEquipment 2024-04-01 2025-03-31 14588923 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 14588923 bus:OrdinaryShareClass1 2023-01-12 2024-03-31 14588923 bus:OrdinaryShareClass2 2024-04-01 2025-03-31 14588923 bus:OrdinaryShareClass2 2023-01-12 2024-03-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 14588923 (England and Wales)

SYFA SQUAD LIMITED

Unaudited Financial Statements
For the financial year ended 31 March 2025
Pages for filing with the registrar

SYFA SQUAD LIMITED

Unaudited Financial Statements

For the financial year ended 31 March 2025

Contents

SYFA SQUAD LIMITED

STATEMENT OF FINANCIAL POSITION

As at 31 March 2025
SYFA SQUAD LIMITED

STATEMENT OF FINANCIAL POSITION (continued)

As at 31 March 2025
Note 31.03.2025 31.03.2024
£ £
Fixed assets
Intangible assets 3 41,978 0
Tangible assets 4 1,966 2,063
43,944 2,063
Current assets
Debtors 5 25,593 3,762
Cash at bank and in hand 317,522 42,178
343,115 45,940
Creditors: amounts falling due within one year 6 ( 283,944) ( 6,761)
Net current assets 59,171 39,179
Total assets less current liabilities 103,115 41,242
Net assets 103,115 41,242
Capital and reserves
Called-up share capital 7 8,991 8,398
Share premium account 676,646 118,650
Profit and loss account ( 582,522 ) ( 85,806 )
Total shareholders' funds 103,115 41,242

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Syfa Squad Limited (registered number: 14588923) were approved and authorised for issue by the Board of Directors. They were signed on its behalf by:

M Morton
Director

15 December 2025

SYFA SQUAD LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2025
SYFA SQUAD LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial period, unless otherwise stated.

General information and basis of accounting

Syfa Squad Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the company's registered office is First Floor,
5 Fleet Place, London, EC4M 7RD, United Kingdom.

The financial statements have been prepared under the historical cost convention and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

The loss for the year reflects the Board’s planned investment in formulation development, ingredient pairing, batch testing, packaging creation, product production, brand positioning, consumer trials, market analysis and operational system build. At 31 March 2025 the company had net assets of £103,115 (2024: £41,242), including cash of £317,522 (2024: £42,178), funded primarily through equity raised from shareholders. The directors consider this capital base and cost profile appropriate for the company’s current stage of development.

Turnover

Turnover is stated net of VAT and trade discounts and is recognised when the significant risks and rewards are considered to have been transferred to the buyer. Turnover from the sale of goods is recognised when the goods are physically delivered to the customer.

Intangible assets

Intangible assets are stated at cost, net of amortisation and any provision for impairment. Amortisation is provided on all intangible assets at rates to write off the cost of each asset over its expected useful life as follows:

Website costs 5 years straight line
Tangible fixed assets

Tangible fixed assets are stated at cost, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets at rates calculated to write off the cost less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Plant and machinery etc. 4 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Impairment of assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Financial instruments

The Company only enters into basic financial instruments and transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to and from related parties and investments in non-puttable ordinary shares.

Financial assets
Basic financial assets, including trade and other debtors, and amounts due from related companies, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Such assets are subsequently carried at amortised cost using the effective interest method.

At the end of each reporting period financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in the Statement of Income and Retained Earnings/Statement of Comprehensive Income.

Financial assets are derecognised when (a) the contractual rights to the cash flows from the asset expire or are settled, or (b) substantially all the risks and rewards of the ownership of the asset are transferred to another party or (c) control of the asset has been transferred to another party who has the practical ability to unilaterally sell the asset to an unrelated third party without imposing additional restrictions.

Financial liabilities
Basic financial liabilities, including trade and other creditors and accruals, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Financial liabilities are derecognised when the liability is extinguished, that is when the contractual obligation is discharged, cancelled or expires.

Financial assets and liabilities are offset and the net amounts presented in the financial statements when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Equity instruments
Equity instruments issued by the company are recorded at the fair value of cash or other resources received or receivable, net of direct issue costs. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

2. Employees

Year ended
31.03.2025
Period from
12.01.2023 to
31.03.2024
Number Number
Monthly average number of persons employed by the company during the year, including directors 0 0

3. Intangible assets

Website costs Total
£ £
Cost
At 01 April 2024 0 0
Additions 46,757 46,757
At 31 March 2025 46,757 46,757
Accumulated amortisation
At 01 April 2024 0 0
Charge for the financial year 4,779 4,779
At 31 March 2025 4,779 4,779
Net book value
At 31 March 2025 41,978 41,978
At 31 March 2024 0 0

4. Tangible assets

Plant and machinery etc. Total
£ £
Cost
At 01 April 2024 2,083 2,083
Additions 492 492
At 31 March 2025 2,575 2,575
Accumulated depreciation
At 01 April 2024 20 20
Charge for the financial year 589 589
At 31 March 2025 609 609
Net book value
At 31 March 2025 1,966 1,966
At 31 March 2024 2,063 2,063

5. Debtors

31.03.2025 31.03.2024
£ £
Trade debtors 151 0
Other debtors 25,442 3,762
25,593 3,762

6. Creditors: amounts falling due within one year

31.03.2025 31.03.2024
£ £
Trade creditors 11,619 4,761
Other creditors 272,325 2,000
283,944 6,761

7. Called-up share capital

31.03.2025 31.03.2024
£ £
Allotted, called-up and fully-paid
839,849 Founder ordinary shares of £ 0.01 each 8,398 8,398
59,298 Investor ordinary shares of £ 0.01 each (31.03.2024: nil shares) 593 0
8,991 8,398